15.1 Emerging drug targets and novel compounds

Psychopharmacology is evolving rapidly, with new drug targets and compounds emerging. Scientists are exploring glutamate modulators, neuropeptides, and neuroplasticity enhancers to treat mental health conditions more effectively.

Novel psychoactive compounds, including cannabinoids and psychedelics, show promise for various disorders. Researchers are also investigating epigenetic modifiers and microbiome-targeted therapies as innovative approaches to mental health treatment.

Glutamate and Neuropeptide Modulators

NMDA Receptor and Neuropeptide Modulation

Top images from around the web for NMDA Receptor and Neuropeptide Modulation

• 

  Discovery and development of memantine and related compounds - Wikipedia View original

  Is this image relevant?

• 

  January | 2021 | Nyby's Nerdy Neuroscience Narratives View original

  Is this image relevant?

• 

  Discovery and development of memantine and related compounds - Wikipedia View original

  Is this image relevant?

• 

  January | 2021 | Nyby's Nerdy Neuroscience Narratives View original

  Is this image relevant?

1 of 2

Top images from around the web for NMDA Receptor and Neuropeptide Modulation

• 

  Discovery and development of memantine and related compounds - Wikipedia View original

  Is this image relevant?

• 

  January | 2021 | Nyby's Nerdy Neuroscience Narratives View original

  Is this image relevant?

• 

  Discovery and development of memantine and related compounds - Wikipedia View original

  Is this image relevant?

• 

  January | 2021 | Nyby's Nerdy Neuroscience Narratives View original

  Is this image relevant?

1 of 2

• NMDA receptor modulators alter glutamate signaling in the brain
  • Function by binding to specific sites on NMDA receptors
  • Can enhance or inhibit receptor activity
  • Potential applications in treating mood disorders and cognitive impairment
  • Examples include ketamine (rapid-acting antidepressant) and memantine (Alzheimer's treatment)
• Neuropeptide modulators target specific signaling molecules in the nervous system
  • Affect various physiological processes including pain, stress, and appetite
  • Can act as agonists or antagonists to neuropeptide receptors
  • Promising for treating anxiety, depression, and addiction
  • Includes substances like oxytocin (social bonding) and substance P antagonists (pain relief)

Neuroplasticity and Inflammation Regulation

• Neuroplasticity enhancers promote brain adaptability and rewiring
  • Stimulate the growth of new neural connections
  • Enhance synaptic strength and efficiency
  • Potential to improve learning, memory, and recovery from brain injuries
  • Compounds like brain-derived neurotrophic factor (BDNF) boosters show promise
• Neuroinflammation inhibitors reduce harmful inflammatory processes in the brain
  • Target specific inflammatory pathways and molecules
  • May slow progression of neurodegenerative diseases
  • Could improve symptoms in conditions like multiple sclerosis and Alzheimer's
  • Anti-inflammatory agents (NSAIDs) and specialized cytokine inhibitors under investigation

Novel Psychoactive Compounds

Cannabinoid System Targets

• Cannabinoid system targets interact with endocannabinoid receptors
  • Affect mood, pain perception, appetite, and memory
  • Include both synthetic compounds and plant-derived cannabinoids
  • Potential therapeutic applications for chronic pain, epilepsy, and anxiety disorders
  • Examples encompass CBD (non-psychoactive component of cannabis) and synthetic CB1 receptor agonists
• Cannabinoid research focuses on developing targeted therapies
  • Aims to maximize therapeutic benefits while minimizing psychoactive effects
  • Explores the entourage effect of multiple cannabinoids working together
  • Investigates the role of lesser-known cannabinoids (CBG, CBN)
  • Development of cannabinoid-based medications (Epidiolex for epilepsy)

Psychedelic Compounds and Their Potential

• Psychedelic compounds alter consciousness and perception
  • Act on serotonin receptors, particularly 5-HT2A
  • Show promise in treating depression, anxiety, and addiction
  • Being studied for their potential to induce neuroplasticity
  • Include substances like psilocybin (magic mushrooms) and LSD
• Research into psychedelics explores various therapeutic approaches
  • Microdosing regimens for mood enhancement and creativity
  • Guided psychedelic-assisted psychotherapy sessions
  • Investigation of non-hallucinogenic analogs of psychedelics
  • Development of more targeted compounds with reduced side effects

Emerging Biological Targets

Epigenetic Modifiers and Gene Expression

• Epigenetic modifiers alter gene expression without changing DNA sequence
  • Target processes like DNA methylation and histone modification
  • Can potentially reverse or mitigate effects of environmental stressors
  • Show promise in treating mood disorders and addiction
  • Include compounds like HDAC inhibitors and DNA methyltransferase inhibitors
• Epigenetic research in psychiatry focuses on several key areas
  • Understanding how early life experiences affect gene expression
  • Developing biomarkers for psychiatric disorders based on epigenetic patterns
  • Exploring transgenerational effects of epigenetic changes
  • Investigating epigenetic changes associated with psychotropic medication use

Microbiome-Targeted Therapies

• Microbiome-targeted therapies aim to modulate gut-brain axis
  • Focus on altering composition of gut microbiota
  • May influence neurotransmitter production and immune function
  • Show potential in treating depression, anxiety, and autism spectrum disorders
  • Include probiotics, prebiotics, and fecal microbiota transplantation
• Research into microbiome-brain connection explores various mechanisms
  • Investigation of how gut bacteria produce neurotransmitters
  • Study of the vagus nerve's role in gut-brain communication
  • Examination of the impact of diet on microbiome composition and mental health
  • Development of personalized microbiome-based interventions for psychiatric disorders